Clinical Trials List
Protocol NumberCPDR001X2X01B
Active
2019-08-01 - 2030-04-30
Phase I
Recruiting1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 徐偉勛 醫學研究部
- HUAI-CHENG HUANG Division of Hematology & Oncology
- MING YAO Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- Yu-Chieh Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
130 participants
